April Spotlight: Biotech’s Best Podcasts
As the life sciences has grown, so have the ways that professionals in the industry retrieve information or learn about its latest developments. And so, more and more podcasts have been covering various important topics in the industry and providing unique insights.
Here is a listing of podcasts that we recommend:
- The Bio Report/RARECast. Daniel S. Levine is an award-winning business journalist who has reported on the life sciences, economic development, and business policy issues throughout his 25-year career. He founded Levine Media Group in 2013, which produces The Bio Report and RARECast podcasts.
- Mendelspod. Mendelspod was founded in 2011 by Theral Timpson and Ayanna Monteverdi to advance life science research, connecting people and ideas. Influenced by the thinking tools developed by Eli Goldratt, the founders bring a unique approach to media in the life sciences.
- Signal, a biweekly, 20-minute show that “sorts through the flood of health and medical news to deliver stories of the next development, controversy or breakthrough that will affect us all.” Hosted by Luke Timmerman and CNBC biotech and pharma reporter Meg Tirrell.
- Human Proof of Concept: Human Proof of Concept is the podcast that demystifies the inner workings of venture-backed medical innovation, providing access and insights from the key players who shape the space.
- Bay State Biotech Report: Bloomberg biotechnology reporter Doni Bloomfield and Boston radio host Anne Mostue discuss the latest in biotech news from the Boston area and across the nation.
- Tech Tonics: A twice-monthly program focused on the people and passion at the intersection of technology and health. Hosted by Lisa Suennen and David Shaywitz (the co-authors of “Tech Tonics: Can Passionate Entrepreneurs Heal Healthcare With Technology?”) the show draws on their experience in business, medicine, and health-IT.
- Novel Targets: Pieter Droppert and Sally Church host this podcast that “(brings) to life the science around innovative new drugs, gene and cell therapies.”
Featured podcast: The latest from Signal